Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 1040)

São Paulo 04014-002

0 studies enrolling now · 1 studies all time

What they study most

Prostatic Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) — Completed